January 15, 2021

 The new guide, Managing Myopia: A Clinical Response to the Growing Epidemic, aims to improve on the fact that only five percent of eye care practitioners worldwide are actually engaged in myopia management. 

 AOA President-Elect Robert Layman, OD, and Johnson & Johnson Vision’s Noel Brennan, BOptom, MScOptom, PhD, FAAO, spoke with Review of Myopia Management’s John Sailer about their organizations’ involvement in creating this new guide along with the American Academy of Optometry, the Association of Schools and Colleges of Optometry, and the Singapore Optometric Association.

 Listen to this podcast to learn what this new guide has to offer eye care professionals, patients, and parents in regards to slowing the onset and progression of myopia, and hear what we can expect from Johnson & Johnson Vision “over the next year or so.”

 Managing Myopia: A Clinical Response to the Growing Epidemic is available to download here.

The American Academy of Ophthalmology’s Myopia Task Force brought together experts on myopia from around the world to develop an action plan to delay the onset of myopia in children and slow its progression. Review of Myopia Management’s John Sailer recently interviewed the leader of the AAO’s Myopia Task Force, Richard L. Abbott, MD, to discuss how they will implement some next steps, including: 

·      educating the health care community, public policy makers, and the public about the public health burden imposed by myopia
·      promoting myopia as an important public health concern both nationally and internationally

·      working with the pediatric and family physician organizations to encourage the value of outdoor time for children and to encourage the early diagnosis of children

 Listen to discover how the AAO is working with global ophthalmological organizations as well as U.S. organizations such as the American Academy of Family Physicians, the American Academy of Optometry, and the American Academy of Pediatrics, and learn more about the AAO’s upcoming white paper on the subject.

Following news of the success of the recent Game On: Battling Myopia In Real Life social media campaign from the Global Myopia Awareness Coalition (GMAC), Review of Myopia Management’s John Sailer interviewed GMAC Board Chair Matt Oerding about the success of the initiative’s 350 million total impressions encouraging parents to seek treatment options for their children’s myopia.

Learn how optometrists certified in this program can fit the first and only soft contact lens the FDA has approved for slowing the progression of myopia in children eight to 12 years of age at the initiation of treatment in this discussion with those who are certified in this breakthrough technology.

*  Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

 Presenting Ortho-K to patients and parents can be an uphill climb. You often need to communicate the very concept of Ortho-K, describe the process it entails, set expectations and establish the overall value of it. As a part of the The Ortho-K Knowledge Bank, Steven Turpin, OD, MS, offers advice on successfully making Ortho-K a part of your practice. 

Discussion with Judith Stern, BOptom, and Michael Morton, BOptom, of the Brien Holden Vision Institute, Part 3. Moderated by Roger Mummert, Jobson Optical Group.

Discussion with Judith Stern, BOptom, and Michael Morton, BOptom, of the Brien Holden Vision Institute, Part 2. Moderated by Roger Mummert, Jobson Optical Group.

Discussion with Judith Stern, BOptom, and Michael Morton, BOptom, of the Brien Holden Vision Institute, Part 1. Moderated by Roger Mummert, Jobson Optical Group.